PTEN公司
胸腺瘤
免疫组织化学
基质金属蛋白酶
临床意义
病理
医学
癌症研究
生物
内科学
细胞凋亡
生物化学
PI3K/AKT/mTOR通路
作者
Zhuang-shi Huang,Feng Shi,Dong-hong Fu,Yan-he Su,Wan-li Lu
出处
期刊:Chinese journal of oncology
日期:2010-01-01
卷期号:32 (1): 37-39
标识
DOI:10.3760/cma.j.issn.0253-3766.2010.01.009
摘要
Objective To evaluate the expression of PTEN, MMP-2 and MMP-9 in thymomas and their correlation with clinical significance. Methods Immunohistochemical S-P assay was used to detect the expression of PTEN, MMP-2 and MMP-9 in 45 thymomas and 16 non-neoplastic thymuses. Results The positive rate of PTEN, MMP-2 and MMP-9 expression in 45 thymomas were 53.5% , 48.9% and 62.2%, respectively. There were significant differences between non-neoplastic thymus and thymomas ( P 〈 0. 05 ). The expression of PTEN, MMP-2 correlated with histological type (P 〈 0.05 ) and different clinical stage of the thymoma (P 〈0.01 ). The expression of MMP-9 was not correlated with histological type and different clinical stages of thymoma ( P 〉 0.05 ). Conclusion PTEN, MMP-2 and MMP-9 may play an important role in the occurrence and development of thymoma. The expression of PTEN and MMP-2 correlates with the malignance and the aggression of thymoma.
Key words:
Thymoma; PTEN gene ; MMP-2 ; MMP-9
科研通智能强力驱动
Strongly Powered by AbleSci AI